ME2 - malic enzyme 2 Gene
生物種: Felis catus
遺伝子タイプ: protein coding
遺伝子ID: 101092963
ME2 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| XM_003995198.5 | XP_003995247.1 | NAD-dependent malic enzyme, mitochondrial isoform X1 |
| XM_045042305.1 | XP_044898240.1 | NAD-dependent malic enzyme, mitochondrial isoform X2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NAD-dependent malic enzyme, mitochondrial |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Pre-clinical Phase
Bioactive Molecules
(90)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-15648B | GSK-J4 | 99.45% | Unkown | |
| HY-D0858 | MES | 99.93% | Unkown | |
| HY-15227 | EPZ004777 | 99.74% | Unkown | |
| HY-D0858A | MES monohydrate | 99.98% | Unkown | |
| HY-15648F | GSK-J4 hydrochloride | Inhibitor | 99.01% | Unkown |
| HY-154812 | Gintemetostat | Inhibitor | 99.81% | Unkown |
| HY-15648 | GSK-J1 | Inhibitor | 99.94% | Unkown |
| HY-162275 | JMJD1C-IN-1 | 99.96% | Unkown | |
| HY-13808 | UNC 0631 | Inhibitor | 99.27% | Unkown |
| HY-152775 | RK-701 | Inhibitor | 98.01% | Unkown |
| HY-D0858C | MES hydrate | 99.90% | Unkown | |
| HY-157251 | UNC8153 TFA | Degrader | 99.92% | Unkown |
| HY-145103 | UNC6934 | Antagonist | 98.24% | Unkown |
| HY-D0858S | MES-d13 | 99.93% | Unkown | |
| HY-13807 | UNC0646 | Inhibitor | 99.38% | Unkown |
| HY-D0858E | MES potassium | 99.88% | Unkown | |
| HY-15227A | EPZ004777 hydrochloride | 98.92% | Unkown | |
| HY-100360 | MS049 | Inhibitor | 98.0% | Unkown |
| HY-15648A | GSK-J2 | Control | 99.75% | Unkown |
| HY-12033S2 | 2-Methoxyestradiol-d5 | 98.67% | Unkown | |
| HY-66025 | Fmoc-Lys(Me)2-OH hydrochloride | 97.52% | Unkown | |
| HY-150510A | MS8511 hydrochloride | Inhibitor | 98.07% | Unkown |
| HY-161759 | MS152 | Inhibitor | 99.36% | Unkown |
| HY-162749A | G9D-4 TFA | 99.44% | Unkown | |
| HY-13808R | UNC 0631 (Standard) | Inhibitor | 99.54% | Unkown |
| HY-183058 | EZM8266 | Inhibitor | 98.24% | Unkown |
| HY-168992A | UNC6535 TFA | / | Unkown | |
| HY-156285 | ZZM-1220 | 98.74% | Unkown | |
| HY-15648D | GSK-J1 lithium salt | Inhibitor | 98.33% | Unkown |
| HY-128579 | DW14800 | Inhibitor | 99.12% | Unkown |
| HY-150510 | MS8511 | Inhibitor | / | Unkown |
| HY-15313C | CBB1007 trihydrochloride | Inhibitor | 97.08% | Unkown |
| HY-157251A | UNC8153 | Degrader | 99.61% | Unkown |
| HY-161313 | DYB-03 | Inhibitor | 99.49% | Unkown |
| HY-164456 | AMI-408 | Inhibitor | / | Unkown |
| HY-D0858D | MES hemisodium | 98.0% | Unkown | |
| HY-116971 | DCG066 | 99.78% | Unkown | |
| HY-120766 | NCDM-32B | Inhibitor | 97.0% | Unkown |
| HY-162749 | G9D-4 | / | Unkown | |
| HY-168992 | UNC6535 | Inhibitor | / | Unkown |
| HY-44062 | G9a-IN-1 | Inhibitor | 98.12% | Unkown |
| HY-P4895 | (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin | Antagonist | 99.20% | Unkown |
| HY-15313 | CBB1007 | Inhibitor | / | Unkown |
| HY-15313B | CBB1007 hydrochloride | Inhibitor | 98.0% | Unkown |
| HY-100360A | MS049 dihydrochloride | Inhibitor | / | Unkown |
| HY-168968S | ZJY-54 | Inhibitor | / | Unkown |
| HY-115619 | EPZ004777 formate | / | Unkown | |
| HY-12033S | 2-Methoxyestradiol-13C,d3 | / | Unkown | |
| HY-12033S1 | 2-Methoxyestradiol-13C6 | / | Unkown | |
| HY-122595 | EZH2-IN-1 | Inhibitor | / | Unkown |
| HY-128931 | NH2-Ph-C4-acid-NH2-Me | / | Unkown | |
| HY-138604 | 5'-O-DMT-N6-Me-2'-dA | Activator | 98.00% | Unkown |
| HY-148829 | MS40 | Degrader | / | Unkown |
| HY-154224 | 2’-O-Me-2-thio-U-3’-phos phoramidite | / | Unkown | |
| HY-155817 | UNC7096 | Chemical | / | Unkown |
| HY-15648G | GSK-J1 sodium | Inhibitor | / | Unkown |
| HY-15648I | GSK-J2 sodium | Inhibitor | / | Unkown |
| HY-161787 | G9a-IN-2 | Inhibitor | / | Unkown |
| HY-168497 | C-MS023 | Inhibitor | / | Unkown |
| HY-173590 | AW4 | Inhibitor | / | Unkown |
| HY-175821 | PRMT1-IN-3 | / | Unkown | |
| HY-176283 | Tubulin/LSD1-IN-1 | / | Unkown | |
| HY-178378 | G9a-IN-4 | / | Unkown | |
| HY-179229 | LSD1-IN-47 | Inhibitor | / | Unkown |
| HY-179427 | NSD2/H3K36me2 modulator-1 | / | Unkown | |
| HY-179650 | NSD2-PWWP1-IN-5 | / | Unkown | |
| HY-179651 | NSD2-PWWP1-IN-6 | Inhibitor | / | Unkown |
| HY-180553 | NSD2-IN-6 | Inhibitor | / | Unkown |
| HY-183105 | DC551040 | / | Unkown | |
| HY-P10819 | S9-CMC1 TFA | / | Unkown | |
| HY-P2014 | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,Tyr-NH29)-Vasotocin | Antagonist | / | Unkown |
| HY-P2253 | H3K27(Me2) (15-34) | / | Unkown | |
| HY-P4397 | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin | / | Unkown | |
| HY-RS02465 | CELSR1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08271 | ME2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W657887 | GSK-3β/G9a-IN-1 | Inhibitor | / | Unkown |
| HY-134075 | 2-Amino-2'-O-methyladenosine | / | Unkown | |
| HY-169217 | CYP3A4-IN-4 | Inhibitor | / | Unkown |
| HY-178568 | DMTr-S-5-C-Me-2'-O-Me-rA(Bz)-3'-CE-phosphoramidite | / | Unkown | |
| HY-178569 | DMTr-S-5-C-Me-2'-O-Me-rC(Ac)-3'-CE-phosphoramidite | / | Unkown | |
| HY-178643 | DMTr-S-5-C-Me-2'-O-Me-rU-3'-CE-phosphoramidite | / | Unkown | |
| HY-178660 | DMTr-R-5'-C-Me-2'-O-Me-rA(Bz)-3'-CE-phosphoramidite | / | Unkown | |
| HY-178663 | DMTr-S-5-C-Me-2'-F-dA(Bz)-3'-CE-phosphoramidite | / | Unkown | |
| HY-182110 | 5-Me-2'-Deoxyzebularine-CE phosphoramidite | / | Unkown | |
| HY-P1162 | (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin | Antagonist | / | Unkown |
| HY-P5006 | (d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin | Antagonist | / | Unkown |
| HY-RS17416 | Tcf4 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17680 | Me2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18501 | Tcf3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24141 | Me2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service